Alessandro Marco Marco Minisini (Alessandro Marco Minisini)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Peritoneal Dialysis

Top Venues

Pigment cell & melanoma research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Joan Albanell, José Manuel Peréz-García, Juan Miguel Gil-Gil, Curigliano Giuseppe, Manuel Ruiz Borrego, Laura Comerma, Joan Gibert, Meritxell Bellet-Ezquerra, Begoña Bermejo, Lourdes Calvo Martinez, Juan R De la Haba-Rodríguez, Enrique Espinosa, Alessandro Marco Marco Minisini, Vanesa Quiroga, Ana Santaballa Bertran, Leonardo Mina, Beatriz Bellosillo, Federico Rojo, Silvia Menéndez, Miguel Sampayo, Ramona Mihaela Popa, Andrea Malfettone, Javier Cortes, Antonio Llombart
Palbociclib Rechallenge for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Donatella Iacono, Maria Grazia Vitale, Debora Basile, Giacomo Pelizzari, Marika Cinausero, Elena Poletto, Gaetano Pascoletti, Alessandro Marco Marco Minisini
Immunotherapy for older patients with melanoma: From darkness to light? Pigment cell & melanoma research 34 (3) (2020)
Giacomo Pelizzari, Debora Basile, Silvia Zago, Camilla Lisanti, Michele Bartoletti, Lucia Bortot, Maria Grazia Vitale, Valentina Fanotto, Serena Barban, Marika Cinausero, Marta Bonotto, Lorenzo Gerratana, Mauro Mansutti, Francesco Curcio, Gianpiero Fasola, Alessandro Marco Marco Minisini, Fabio Puglisi
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker. Cancers 11 (9) (2019)
Elisa Bertoli, Marco Giavarra, Maria Grazia Vitale, Alessandro Marco Marco Minisini
Neuroblastoma rat sarcoma mutated melanoma: That's what we got so far. Pigment cell & melanoma research 32 (6) (2019)